Imaging response in neuroendocrine tumors treated with targeted therapies: the experience of sunitinib.
Target Oncol
; 7(2): 127-33, 2012 Jun.
Article
in En
| MEDLINE
| ID: mdl-22585430
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrroles
/
Neuroendocrine Tumors
/
Angiogenesis Inhibitors
/
Indoles
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Target Oncol
Journal subject:
NEOPLASIAS
Year:
2012
Document type:
Article
Affiliation country:
Francia
Country of publication:
Francia